<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04596254</url>
  </required_header>
  <id_info>
    <org_study_id>20.01.AMZ_BIO</org_study_id>
    <nct_id>NCT04596254</nct_id>
  </id_info>
  <brief_title>Detection of Gut Metabolites in Mother's Milk Following Juice Intake</brief_title>
  <official_title>Prospective Human Specimen Collection for Medical Research</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Amazentis SA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Amazentis SA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of the biological sample collection is to assess the presence of gut metabolites in&#xD;
      human breast milk (BM) samples obtained prospectively from healthy lactating mothers and&#xD;
      after consumption of fruit juice.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 15, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in levels of gut metabolites in breast milk following juice intake</measure>
    <time_frame>7 days</time_frame>
    <description>Collection before and after juice intake</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">7</enrollment>
  <condition>Healthy Diet</condition>
  <arm_group>
    <arm_group_label>Juice Intake</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pomegranate Juice</intervention_name>
    <description>Collection of Mother's milk before and after juice consumption</description>
    <arm_group_label>Juice Intake</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  20-40 yrs. female subjects with no lactation problems&#xD;
&#xD;
          -  Healthy and term delivery&#xD;
&#xD;
          -  Healthy dietary intake (vegetarian or omnivore)&#xD;
&#xD;
          -  Agree to donate breast milk (not colostrum)&#xD;
&#xD;
          -  First 6 months of lactation&#xD;
&#xD;
          -  Subjects agree to consumer 8oz. of pomegranate juice for a week prior to 2nd&#xD;
             collection&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  &lt;20 yrs or &gt;40 yrs. of age&#xD;
&#xD;
          -  Subjects with lactation problems&#xD;
&#xD;
          -  Preterm delivery&#xD;
&#xD;
          -  Colostrum samples&#xD;
&#xD;
          -  Lactation&gt;6 months&#xD;
&#xD;
          -  Subjects fail to drink juice for at least a week&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anurag SIngh, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Amazentis SA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Valleywise Health Biobank</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85008</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>October 15, 2020</study_first_submitted>
  <study_first_submitted_qc>October 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 22, 2020</study_first_posted>
  <last_update_submitted>September 3, 2021</last_update_submitted>
  <last_update_submitted_qc>September 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

